IMM-101
N/A
Report date: 2022/07/19 16:22:54
Base Information
Drug NameIMM-101
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmodulon Therapeutics Ltd
China Registration ClassN/A
Develop Information
Active CompaniesImmodulon Therapeutics Ltd
Inactive CompaniesUniversity Of Glasgow
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A